{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T21:31:32Z","timestamp":1792359092197,"version":"4.4.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,17]]},"DOI":"10.7759\/cureus.16444","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T18:32:27Z","timestamp":1626546747000},"source":"Crossref","is-referenced-by-count":4,"title":["Primary Cutaneous Cryptococcosis in a Patient on Fingolimod: A Case Report"],"prefix":"10.7759","author":[{"given":"Deena","family":"Dahshan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofanit A","family":"Dessie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2020.e00810","article-title":"Primary cutaneous cryptococcal infection due to fingolimod-induced lymphopenia with literature review","volume":"21","author":"Patil SM","year":"2020","unstructured":"Patil SM, Beck PP, Arora N, Acevedo BA, Dandachi D. Primary cutaneous cryptococcal infection due to fingolimod-induced lymphopenia with literature review. IDCases. 2020, 21:e00810. 10.1016\/j.idcr.2020.e00810","journal-title":"IDCases"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.4259","article-title":"Primary cutaneous Cryptococcus in a patient with multiple sclerosis treated with fingolimod","volume":"73","author":"Forrestel AK","year":"2016","unstructured":"Forrestel AK, Modi BG, Longworth S, Wilck MB, Micheletti RG. Primary cutaneous Cryptococcus in a patient with multiple sclerosis treated with fingolimod. JAMA Neurol. 2016, 73:355-6. 10.1001\/jamaneurol.2015.4259","journal-title":"JAMA Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7224\/1537-2073.2018-080","article-title":"Case report: fingolimod and cryptococcosis: collision of immunomodulation with infectious disease","volume":"21","author":"Samudralwar RD","year":"2019","unstructured":"Samudralwar RD, Spec A, Cross AH. Case report: fingolimod and cryptococcosis: collision of immunomodulation with infectious disease. Int J MS Care. 2019, 21:275-80. 10.7224\/1537-2073.2018-080","journal-title":"Int J MS Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.55.7255","article-title":"Disseminated cryptococcosis in a 63-year-old patient with multiple sclerosis treated with fingolimod","volume":"55","author":"Seto H","year":"2016","unstructured":"Seto H, Nishimura M, Minamiji K, Miyoshi S, Mori H, Kanazawa K, Yasuda H. Disseminated cryptococcosis in a 63-year-old patient with multiple sclerosis treated with fingolimod. Intern Med. 2016, 55:3383-6. 10.2169\/internalmedicine.55.7255","journal-title":"Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-210898","article-title":"Cutaneous Cryptococcus: marker for disseminated infection","volume":"2015","author":"Srivastava GN","year":"2015","unstructured":"Srivastava GN, Tilak R, Yadav J, Bansal M. Cutaneous Cryptococcus: marker for disseminated infection. BMJ Case Rep. 2015, 2015:bcr2015210898. 10.1136\/bcr-2015-210898","journal-title":"BMJ Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1086\/345956","article-title":"Primary cutaneous cryptococcosis: a distinct clinical entity","volume":"36","author":"Neuville S","year":"2003","unstructured":"Neuville S, Dromer F, Morin O, Dupont B, Ronin O, Lortholary O. Primary cutaneous cryptococcosis: a distinct clinical entity. Clin Infect Dis. 2003, 36:337-47. 10.1086\/345956","journal-title":"Clin Infect Dis"},{"key":"ref7","article-title":"Cryptococcal Meningitis","author":"Pescador Ruschel MA","year":"2020","unstructured":"Pescador Ruschel MA, Thapa B. Cryptococcal Meningitis. StatPearls Publishing, Treasure Island, FL; 2020."},{"key":"ref8","article-title":"Cutaneous cryptococcosis--primary versus secondary disease. Report of two cases with review of literature","volume":"15","author":"Ng WF","year":"1993","unstructured":"Ng WF, Loo KT. Cutaneous cryptococcosis--primary versus secondary disease. Report of two cases with review of literature. Am J Dermatopathol. 1993, 15:372-7.","journal-title":"Am J Dermatopathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2016.07.015","article-title":"Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: a case report and review of literature","volume":"9","author":"Grebenciucova E","year":"2016","unstructured":"Grebenciucova E, Reder AT, Bernard JT. Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: a case report and review of literature. Mult Scler Relat Disord. 2016, 9:158-62. 10.1016\/j.msard.2016.07.015","journal-title":"Mult Scler Relat Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/1369378031000137224","article-title":"Primary cutaneous cryptococcosis in immunocompetent and immunocompromised hosts","volume":"41","author":"Christianson JC","year":"2003","unstructured":"Christianson JC, Engber W, Andes D. Primary cutaneous cryptococcosis in immunocompetent and immunocompromised hosts. Med Mycol. 2003, 41:177-88. 10.1080\/1369378031000137224","journal-title":"Med Mycol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907839","article-title":"Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis","volume":"362","author":"Cohen JA","year":"2010","unstructured":"Cohen JA, Barkhof F, Comi G, et al.. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med. 2010, 362:402-15. 10.1056\/NEJMoa0907839","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/59748-primary-cutaneous-cryptococcosis-in-a-patient-on-fingolimod-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:42Z","timestamp":1707507162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/59748-primary-cutaneous-cryptococcosis-in-a-patient-on-fingolimod-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,17]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.16444","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,17]]}}}